- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Oncoinvent ASA (ONCIN)
Track today's live Oncoinvent (ONCIN) share price, performance and key data on this page with our current Oslo:ONCIN stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Oncoinvent share price on the Oslo exchange. Use the dropdown to switch exchange for the ONCIN share price, head to our technical summary section, which provides analysis on Oncoinvent share price buy/sell indicators using real-time data (or discuss the Oncoinvent (ONCIN) stock price today with other investors in the Oncoinvent OL share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current OL:ONCIN share price (ISIN: NO0013711713) to enhance your trading decisions with our free investment tools and resources.
What Is the Oncoinvent ASA Share Price Today?
The Oncoinvent share price today is 132.00.
What Is the Stock Symbol for Oncoinvent ASA
The stock symbol (or 'ticker') for Oncoinvent ASA is "ONCIN."
What Stock Exchange Does Oncoinvent ASA Trade On?
Oncoinvent ASA is listed and trades on the Oslo stock exchange.
Is Oncoinvent ASA a Good Stock to Buy?
Determining whether Oncoinvent (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current OL:ONCIN share price (ISIN: NO0013711713) to enhance your trading decisions with our free investment tools and resources.
What Is the Oncoinvent ASA Share Price Today?
The Oncoinvent share price today is 132.00.
What Is the Stock Symbol for Oncoinvent ASA
The stock symbol (or 'ticker') for Oncoinvent ASA is "ONCIN."
What Stock Exchange Does Oncoinvent ASA Trade On?
Oncoinvent ASA is listed and trades on the Oslo stock exchange.
Is Oncoinvent ASA a Good Stock to Buy?
Determining whether Oncoinvent (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Oslo
Currency in NOK
132.00
-3.00(-2.22%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
128.50
139.00
52 wk Range
40.10
144.00
ONCIN is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
128.50139.00
52 wk Range
40.10144.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ONCIN Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
112.50
Downside
-14.77%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Strong Buy
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 112.50
(-14.77% Downside)
Earnings
Latest Release
27/08/2026
EPS / Forecast
-15.20 / --
Revenue / Forecast
8.2M / --
Compare ONCIN to Peers and Sector
Metrics to compare | ONCIN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipONCINPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.6x | −2.6x | −0.4x | |
PEG Ratio | −0.05 | 0.00 | 0.00 | |
Price/Book | 7.6x | 3.7x | 2.6x | |
Price / LTM Sales | 25.1x | 33.8x | 3.0x | |
Upside (Analyst Target) | −15.4% | 248.4% | 56.5% | |
Fair Value Upside | Unlock | −4.6% | 8.5% | Unlock |
Oncoinvent ASA, a clinical stage company, develops radiopharmaceutical therapies against cancer. Its lead product candidate is Radspherin, an alpha-radiation therapy candidate for treating cancer that have spread to body cavities, including peritoneum in two phase 1/2a trials and one randomized phase 2 trial. Oncoinvent ASA is based in Oslo, Norway.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Oncoinvent (Oslo: ONCIN) Share Price Today?
The Oncoinvent stock price today is 132.00 NOK.
What Stock Exchange Does Oncoinvent (ONCIN) Trade On?
Oncoinvent is listed and trades on the Oslo Stock Exchange.
What Is the Ticker (Stock Symbol) for Oncoinvent?
The stock symbol (also called a 'ticker') for Oncoinvent is "ONCIN."
What Is the Current Oncoinvent Market Capitalisation?
As of today, Oncoinvent (Oslo: ONCIN) market cap is 604.59M NOK.
What Is Oncoinvent's (ONCIN) Earnings Per Share (TTM)?
The Oncoinvent EPS is currently -57.11 (Trailing Twelve Months).
When Is the Next Oncoinvent Earnings Date?
Oncoinvent's next earnings report will be released on 28/10/2026.
Is ONCIN a Buy or Sell From a Technical Analyst Perspective?
Based on today's Oncoinvent moving averages and other technical indicators, the daily buy/sell signal for ONCIN stock is Strong Buy.
How Many Times Has Oncoinvent Stock Split?
Oncoinvent has split 4 times. (See the ONCIN stock split history page for full effective split date and price information.)
How Many Employees Does Oncoinvent Have?
Oncoinvent has 42 employees, based on their latest Companies House report.
What is the current trading status of Oncoinvent (Oslo: ONCIN)?
As of 17/09/2026, Oncoinvent (ONCIN) is trading at a share price of 132.00 NOK, with a previous close of 132.00 NOK. The stock has fluctuated within a day range of 128.50 NOK to 139.00 NOK, while its 52-week range spans from 40.10 NOK to 144.00 NOK.
What Is Oncoinvent (ONCIN) Price Target According to Analysts?
The average 12-month price target for Oncoinvent is 112.50 NOK, with a high estimate of 115 NOK and a low estimate of 110 NOK. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an -14.77% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.